Dodge & Cox

Holding/activity history for  Alnylam Pharmaceuticals (ALNY)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 2,317,300 0.57 Reduce 1.24% 0.01 $275.03
2024   Q2 2,346,400 0.54 $243.00
2024   Q1 2,346,400 0.32 $149.45
2023   Q4 2,346,400 0.46 Reduce 2.12% 0.01 $191.41
2023   Q3 2,397,200 0.47 Add 0.50% 0.00 $177.10
2023   Q2 2,385,200 0.50 Reduce 1.44% 0.01 $189.94
2023   Q1 2,420,000 0.55 Reduce 18.29% 0.12 $200.32
2022   Q4 2,961,777 0.81 Reduce 2.68% 0.02 $237.65
2022   Q3 3,043,377 0.85 Reduce 1.78% 0.02 $200.16
2022   Q2 3,098,377 0.54 Reduce 4.64% 0.03 $145.85
2022   Q1 3,249,177 0.55 $163.29
2021   Q4 3,249,177 0.58 Add 4.50% 0.02 $169.58
2021   Q3 3,109,177 0.65 $188.81
2021   Q2 3,109,177 0.60 Add 28.40% 0.13 $169.52
2021   Q1 2,421,492 0.44 Reduce 8.59% 0.04 $141.19
2020   Q4 2,649,161 0.49 Reduce 0.16% 0.00 $129.97
2020   Q3 2,653,461 0.64 Reduce 2.99% 0.02 $145.60
2020   Q2 2,735,261 0.68 Reduce 11.34% 0.09 $148.11
2020   Q1 3,085,261 0.66 Reduce 3.52% 0.02 $108.85
2019   Q4 3,197,761 0.50 $115.17
2019   Q3 3,197,761 0.38 $80.42
2019   Q2 3,197,761 0.34 Add 6.32% 0.02 $72.56
2019   Q1 3,007,761 0.42 Add 6.89% 0.03 $93.45
2018   Q4 2,813,861 0.34 $72.91
2018   Q3 2,813,861 0.34 $87.52
2018   Q2 2,813,861 0.40 $98.49
2018   Q1 2,813,861 0.49 Reduce 42.48% 0.36 $119.10
2017   Q4 4,891,735 0.89 Reduce 11.07% 0.11 $127.05
2017   Q3 5,500,735 0.96 $117.49
2017   Q2 5,500,735 0.68 $79.76
2017   Q1 5,500,735 0.44 Add 1.29% 0.01 $51.25
2016   Q4 5,430,735 0.34 Add 63.44% 0.13 $37.44
2016   Q3 3,322,768 0.40 Add 100.01% 0.20 $67.78
2016   Q2 1,661,330 0.17 Buy 0.17 $55.49